FindTrial
Sign In

A multicenter retrospective study optimizing antidepressant treatment based on pharmacogenomic information in real-world setting

A multicenter retrospective study optimizing antidepressant treatment based on pharmacogenomic information in real-world setting

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300071164
Enrollment
Unknown
Registered
2023-05-06
Start date
2022-11-20
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Interventions

Genomics guides drug therapy:N/A

Sponsors

The First Hospital of Hebei Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
8 Years to 84 Years

Inclusion criteria

Inclusion criteria: To be eligible for the study, patients had to meet all of the following eligibility criteria: 1. Patients with depression who met the Diagnostic and Statistical Manual of Mental Disorders, Fifth edition (DSM-5) definitions; 2. Age and gender are not limited; 3. Patients with genetic testing for antidepressants.

Exclusion criteria

Exclusion criteria: N/A

Design outcomes

Primary

MeasureTime frame
use as directed;use as caution;use with increased caution and with more frequent monitoring;Mutation frequency of gene locus;—

Countries

China

Contacts

Public ContactChun-Hua Zhou

The First Hospital of Hebei Medical University

zhouchunhua80@126.com+86 18633881377

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026